Blog Details

Author - Associate Sanjani Shah 

The Government of India establishes an act which manages the import, produce and dealing out drugs in India. The central idea of the Act is to make certain that the drugs and cosmetics sold in India are safe, secure fruitful and conform to stipulate quality standards. The drugs Act was composed in 1940 in ensuing of recommendations of Chopra Committee established in 1930 by Indian Government. The drugs covered under the Drugs and Cosmetic Act wide varieties of remedial substances, distinctive and medical implementation.

Pursuant the Act cosmetic means any article intended to be rubbed, poured, sprinkled,  or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness or altering the appearance, and includes any article intended for use as a component of cosmetic but does not  include soap. The Act has been additionally amended as Drugs (amendment) Act 1964 (13 of 1964) to include Ayurvedic and Unani drugs.

The Drugs Act, as validated in 1940, has since been amended many times and is now entitled as “The Drugs and Cosmetics Act, 1940”.

The drug laws were publicizing in 1945 December and imposition of these laws started in 1947. To meet the requirements of the time and to sort out any deficiencies observed during the implementation of the laws have been amended from time to time.

The Central Government and State/Union Territory (UT) Governments has the responsibilities of imposing the various Acts. Under the Drugs and Cosmetics Act, drugs are classified in schedules and regulations are permitted for their storage, display, sale, dispensing, leveling, prescribing etc.

The Central Government shall, establish a Board (called The Drugs Technical Advisory Board) to guide the Central Government and the State Governments on technical matters emerging out of the managing of this Act and to effectuate the other functions allocated to it by this Drugs and Cosmetics Act, 1940.

The proposed and elected members of the Board will hold office for three years, but will be entitled for re-nomination and re-election.

The Ministry of Health and Family Welfare on 27 October 2017, has published the Drugs and Cosmetics (Tenth Amendment) Rules, 2017 through official gazette, in exercise of the powers bestowed by section 12 read with section 33 of the Drugs and Cosmetics (D&C) Act, 1940 (23 of 1940); farther after discussion with the Drugs Technical Advisory Board has suggested the following rules to amend the Drugs and Cosmetics Rules, 1945, as:

Duration of license: As per the amendment once a various licenses provide under Form 20, 20A,20B,20BB,20F,20G,21,21A,21B,21BB,Form 25, Form 25B,25F,32,32A,Form 33 and Form 37; whereas advance license also provide in Form 25A will remain valid, if licensee deposits a license retention fee mention to in sub-rule (2) before the expiry of every succeeding five years from the date of its issue, unless, it is suspended or cancelled by the licensing authority.

If the licensee fails to pay license retention fee on or before the due dates as mentioned date as referred to in sub-rule (1), licensee will be liable to pay license retention fee along with a late fee calculated at the rate of 2% of the license fee for every month till six months or part thereof. If licensee will not pay of such fee, the license will regards as cancelled.

Verification of compliance and Inspection for grant of license: The manufacture of drugs which is proposed by establishment is proposed to be conducted or being used, to be inspected jointly by the Drugs Inspectors appointed by the Central Government and State Government under this Drugs and Cosmetics Act, 1940 who will inspect the establishment proposed to be used or being used for the manufacture of drugs.

Inspection for confirmation of compliance: The authority of licensing will cause inspection, by the appointed inspector under the Drugs and Cosmetics Act, 1940, of each premise licensed under this Act, to substantiate compliance with the conditions of license and the provision of Law. Inspection will be done once every three years or as required as per risk based approach.

From March 27, 2017, the Drugs and Cosmetics (Tenth Amendment) law, 2017 is implemented. Following interim outlines to make certain the smooth processing of applications for grant of manufacturing licenses; and combine inspection of manufacturing premises:

Application of license shall complete in all respect as per the provision of Drugs and Cosmetic Act, 1940 and Rules, 1945 should be submitted by manufacture to the corresponding State Licensing Authority.

At least seven days prior to the date of joint inspection the State Licensing Authority should fix date of joint inspection of the manufacturing properties, in coordination with the respective Zonal / Sub Zonal offices of CDSCO.

In case of unavailability of CDSCO Zonal/sub Zonal officers on any specific date, then Drug Inspector from CDSCO (HQ) will do the joint inspection.

For timely inspection and processing of application a proper coordination should be done between State Licensing Authorities, CDSCO HQ and Zonal/sub Zonal offices.premises licence for sale of drugs are inspected at least twice a year.

In case of any flaw in the application in regard of any inspection, then the joint inspection team at the time of inspection may corroborate document and record details of the same in the inspection report.

However, further improvement in the enforcing of the new rules CDSCO will appreciate any valuable feedback or suggestions.